Figure 3. LIFR-AS1 inhibits breast cancer cell migration and invasion.
(A) Breast cancer cell migration was analyzed by wound healing assays after treatment with LIFR-AS1 mimics or siLIFR-AS1. (B) Breast cancer cell invasion was analyzed by transwell invasion assays after treatment with LIFR-AS1 mimics or siLIFR-AS1. **P<0.01, ***P<0.001.